U.S. Auto Components Stock News

In recent weeks, UFC and Good Greek Moving & Storage announced a multiyear marketing partnership that will place Good Greek branding inside selected U.S. UFC Fight Nights and all episodes of Dana White’s Contender Series, supported by athlete-led campaigns, while analysts highlighted initiatives such as Zuffa Boxing and growing sponsorships across UFC and WWE. At the same time, TKO Group Holdings expanded its revolving credit facility to €1.15 billion and continued to push global UFC event...

Streamex (STEX) has been getting fresh attention after teaming up with tZERO to support secondary trading of GLDY, a gold linked tokenized security, on a regulated alternative trading system. See our latest analysis for Streamex. At a share price of US$3.33, Streamex has had a mixed run, with a 7.07% 1 month share price return and 7.07% year to date share price return, but a 26.65% 3 month share price decline and a 71.54% 3 year total shareholder return decline alongside a very large 1 year...

Helios Technologies recently expanded its OpenView display platform by adding CODESYS functionality, allowing customers to program both uControl controllers and OpenView displays within the same industrial development environment while enabling remote visualization and diagnostics through CODESYS WebVisu. This move reinforces Helios’ open software approach and could make its Electronics segment more attractive to OEMs and system integrators seeking interoperable, future-ready HMI...

Federated Hermes, Inc. recently reported fourth-quarter 2025 results with higher revenue and net income year over year, affirmed a US$0.34 quarterly dividend, completed share repurchases under two authorizations, and announced that senior portfolio manager Mark Weiss, CFA, will lead the Prime Liquidity Group when longtime executive Paige Wilhelm retires on July 1, 2026. This combination of solid operating updates and a planned leadership handover in a US$242.7 billion prime money market...

Why Soleno Therapeutics Is Back on Investors’ Radar Soleno Therapeutics (SLNO) is drawing fresh attention after describing 2025 as a transformational year, highlighting early traction for VYKAT XR, and flagging upcoming full financial results alongside a busy investor conference schedule. See our latest analysis for Soleno Therapeutics. The latest 9.75% 1 day share price gain to US$42.32 comes after management framed 2025 as transformational and highlighted early VYKAT XR traction. However,...

Sysco Corporation recently reported its second-quarter and six-month results to December 27, 2025, with sales rising to US$20,762 million for the quarter and US$41,910 million for the half-year, while net income and earnings per share from continuing operations were slightly lower than a year earlier. A new four-year collective bargaining agreement for more than 50 Sysco drivers in Spokane, Washington, featuring a very large wage increase and improved benefits, highlights how the company is...

Hagerty (HGTY) has been drawing attention after recent share price moves, with the stock showing mixed short term performance and a stronger picture over the past year. This has prompted investors to reassess the specialty insurer. See our latest analysis for Hagerty. At a share price of US$12.68, Hagerty’s recent 90 day share price return of 13.82% contrasts with a 1 month share price decline of 3.57%, while the 1 year total shareholder return of 31.4% points to momentum that has played out...

Autolus Therapeutics plc ( NASDAQ:AUTL ) shareholders won't be pleased to see that the share price has had a very rough...

EOG Resources (EOG) recently posted quarterly results, reporting revenue slightly below the prior year while adjusted EPS came in ahead of expectations, supported by strong free cash flow, shareholder payouts, and ongoing interest in natural gas demand. See our latest analysis for EOG Resources. Those earnings helped steady sentiment after a 1 year total shareholder return decline of about 11%, even as the 90 day share price return of roughly 3% and 5 year total shareholder return of about...

How Gen Digital’s recent performance sets the stage for investors Gen Digital (GEN) has drawn attention after a recent stretch of weaker share performance, with the stock showing negative returns over the past week, month, past 3 months and year. Alongside that price pressure, the company reports annual revenue of US$4.47b and net income of US$570.0m, giving investors a concrete baseline to compare its current valuation against recent fundamental results. See our latest analysis for Gen...

Energy Transfer (NYSE:ET) has announced an increase of more than 3% in its quarterly cash distribution. The move aligns with the company’s stated goal of growing distributions by 3% to 5% annually. The update comes alongside plans for substantial expansion investments through 2029. Energy Transfer operates in the midstream segment of the energy sector, focusing on transporting and storing energy commodities. Recent commentary around the company has highlighted financial flexibility and cash...

Why Jumia’s turnaround plan is back in focus Recent commentary around Jumia Technologies (JMIA) and CEO Francis Dufay’s turnaround plan, which includes store closures, logistics expansion, and a profitability goal by 2027, has pushed the e commerce group back onto many investors’ watchlists. See our latest analysis for Jumia Technologies. The latest commentary around the turnaround comes after a mixed stretch for the stock, with a 14.98% 90 day share price return and a very large 217.74% 1...

In recent days, Vital Farms has attracted heightened investor attention as analysts highlight expected earnings growth and reference its track record of beating revenue and earnings estimates. Amid this increased focus, a bullish thesis emphasizing Vital Farms’ premium brand positioning and resilience to egg price volatility has become a key talking point for investors. We’ll now examine how growing optimism around Vital Farms’ earnings outlook influences its investment narrative and...

Why SiriusPoint’s capital moves are on investors’ radar SiriusPoint (SPNT) has drawn fresh attention after announcing it will redeem and later delist all 8 million Series B preference shares, while also reshaping senior underwriting leadership in its North America P&C business. For current and prospective shareholders, these steps raise practical questions about how the balance between preferred and common equity could shift, what happens to financing costs tied to the 8.00% preference...

Atlassian (NasdaqGS:TEAM) has entered a new long term partnership with BNY to support the Williams F1 Team, expanding its presence in global sports sponsorships. Law firm Pomerantz LLP has launched an investigation into potential securities law violations at Atlassian, focusing on possible securities fraud issues. Atlassian, known for collaboration and workflow tools such as Jira and Confluence, sits at the center of how many companies run projects and software development. The fresh tie up...

Omnicom Group (OMC) is back in focus after shareholders approved its 2026 Incentive Award Plan on January 28, 2026, alongside a new US$2.14b shelf registration tied to an employee stock ownership plan. See our latest analysis for Omnicom Group. The approvals come after a softer run in the share price, with a 7 day share price return showing a decline of 4.78% and a 30 day share price return showing a decline of 5.90%. The 1 year total shareholder return is a decline of 9.53%, while the 5 year...

NXP Semiconductors (NasdaqGS:NXPI) has completed the sale of its MEMS sensors business. The company has acquired Aviva Links, a specialist in high speed automotive connectivity technology. These transactions reshape NXP's portfolio with a sharper focus on automotive connectivity solutions. For you as an investor, these moves highlight where NXP Semiconductors, traded as NasdaqGS:NXPI, is choosing to concentrate its resources inside the broader chip industry. The company has long been active...

Blue Bird has proposed an amendment to its certificate of incorporation that would limit the liability of certain officers for breaches of fiduciary duty. The change would be implemented through corporate bylaw updates, subject to shareholder approval. The proposal focuses on reshaping how accountability and legal exposure for specific executives are defined within the company. For investors watching NasdaqGM:BLBD, this governance move sits alongside a share price of $51.06 and recent...

If you are wondering whether NRG Energy at around US$149 per share still offers value after a strong run, this article will help you make sense of what the current price might be implying. The stock has pulled back recently, with a 0.5% decline over the last week and a 10.3% decline over the last month, even though the 1 year return is 47% and the 3 year return is very large at around 4.6x. These moves come as NRG Energy continues to attract attention in the US utilities space, with...

HCA Healthcare (NYSE:HCA) is rolling out AI-driven programs across its hospital network to improve clinical workflows, revenue cycle processes, and patient care. The company recently expanded its collaboration with GE Healthcare to develop an AI-enabled fetal heart rate monitoring tool for use in labor and delivery. Multiple HCA hospitals have received recent recognition for clinical excellence, including placements on national "Best Hospitals" lists. HCA Healthcare, one of the largest...

Lululemon founder Dennis J. Wilson has launched an activist campaign targeting the company’s board and future direction. Wilson plans to file a proxy statement to nominate his own director candidates and submit a business proposal at the 2026 annual meeting. The move raises the possibility of changes to lululemon athletica’s leadership priorities, capital allocation, or growth plans. For investors watching NasdaqGS:LULU, this development comes at a time when the share price is around...

Moderna stock snapshot and recent performance Moderna (MRNA) shares closed at US$42.55 on the latest trading day, with a 1 day return of a 3.4% decline and a 7 day return of an 11.3% decline, setting the stage for a closer look at recent moves. Over the past month the stock has a total return of 37.9%, while the past 3 months show a 79.2% total return and 16.4% over the past year. Longer term, 3 year and 5 year total returns are a 75.0% decline and a 77.1% decline respectively. See our latest...

Definium Therapeutics (DFTX) has been drawing fresh attention after Jefferies and other firms began covering the stock with favorable commentary, highlighting its late stage brain health pipeline and lead candidate DT120. See our latest analysis for Definium Therapeutics. The recent 1 month share price return of 33.65% and 90 day share price return of 51.92% suggest momentum has been building. However, the very large 3 year total shareholder return contrasts with a weaker 5 year total...

Palo Alto Networks (NasdaqGS:PANW) has completed its acquisition of Chronosphere. The deal brings Chronosphere’s observability platform into Palo Alto Networks AI-driven cybersecurity offerings. The combined platform is aimed at real-time detection and automated response across security and IT operations. Palo Alto Networks focuses on cybersecurity products and platforms used by large enterprises, including firewalls, cloud security tools, and AI-driven threat detection. Chronosphere is...